MID-VOLUME · SEX-BALANCED

lurasidone Side Effects

lurasidone (also sold as Latuda) sits MID-VOLUME #233 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 70% of sex-coded reports are female (11,298 F / 4,861 M). Demographics and serious-outcome tables follow.

Data updated 2026-05-15

20,544
FAERS reports

FDA Adverse Event Reporting System extract for lurasidone. Stamp set WATCHLIST · DEATH-MARKED · HOSP-MID. How figures are compiled.

lurasidone reporting skew - 70% of sex-coded reports are female (11,298 F / 4,861 M). Volume band MID-VOLUME #233 of 524 by FAERS report count; caseload WATCHLIST.

Mid-book FAERS page for lurasidone (Latuda) (20,544 reports). Signature SEX-BALANCED. Dominant age band on file: 18-44. Educational reference only.

Counts from the openFDA FAERS extract (2009–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.

ANXIETY leads 1,223 of 20,544 reports

ANXIETY
1,223
FEELING ABNORMAL
1,166
DEPRESSION
1,120
WEIGHT INCREASED
1,077
SOMNOLENCE
1,066
NAUSEA
1,037
INSOMNIA
1,002
SUICIDAL IDEATION
957
FATIGUE
942
DYSKINESIA
818
SUICIDE ATTEMPT
751
TREMOR
705
VOMITING
665
MALAISE
659
SEDATION
613
RESTLESSNESS
600
CONDITION AGGRAVATED
591
BLOOD GLUCOSE INCREASED
584

Who reports · age peak 18-44 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 11,298 (70%)
Male 4,861 (30%)
Unknown 70

Age peak 18-44 (4,006 reports)

0-17 829 (10%)
18-44 4,006 (48%)
45-64 2,699 (32%)
65-74 692 (8%)
75+ 152 (2%)

FAERS filings rising toward 2025

2009 2025

Reactions in Death Reports

Death appears on 564 reports (2.7% - MARKED). Reactions below co-occur in those rows only.

Reaction Reports
COMPLETED SUICIDE 225
DEATH 152
BLOOD GLUCOSE INCREASED 43
CONDITION AGGRAVATED 43
DYSTONIA 43
PERSONALITY CHANGE 43
SUICIDE ATTEMPT 43
DYSKINESIA 42
METABOLIC DISORDER 42
SCHIZOPHRENIA 42
SEDATION 42
ANOSOGNOSIA 41
BLOOD PROLACTIN ABNORMAL 41
DISTURBANCE IN SOCIAL BEHAVIOUR 41
SEXUAL DYSFUNCTION 41
TOXICITY TO VARIOUS AGENTS 27
ADVERSE DRUG REACTION 26
MYOCARDIAL INFARCTION 22

Reactions in Hospitalization Reports

Hospitalization mid-share (2,956, 14.4%). Co-reported reactions:

Reaction Reports
SUICIDAL IDEATION 322
SUICIDE ATTEMPT 221
DEPRESSION 217
ANXIETY 161
CONDITION AGGRAVATED 150
INSOMNIA 146
NAUSEA 139
FALL 138
TREMOR 134
WEIGHT INCREASED 132
PSYCHOTIC DISORDER 125
MANIA 123
AGITATION 119
AGGRESSION 114
WEIGHT DECREASED 110
CONFUSIONAL STATE 106
MENTAL DISORDER 106
VOMITING 105
How to read lurasidone FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)

FAERS holds 20,544 voluntary reports linked to lurasidone (Latuda), 2009-2025. Death is listed on 564 (2.7%). Hospitalization appears on 2,956 (14.4%). Top co-reported indication: Product Used For Unknown Indication.

Mid-volume extract - treat DEATH-MARKED · HOSP-MID as signal-detection rates next to 70% of sex-coded reports are female (11,298 F / 4,861 M).

Read with lurasidone

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.